ORIG3N

United States
Panora, Iowa, United States, 02210

Company profile

ORIG3N company profile

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases with targets in heart, liver, and neurodegenerative indications. It was founded in 2014 and is based in Boston, Massachusetts.

Business identity

Contact email
[email protected]
Operating status
Closed
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-04-10

Headquarters

Postal code
02210
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
5
Total equity funding
$76.2M
Last funding
Series Unknown / $26.2M / 2020-09-09
Last equity funding
Series Unknown / $26.2M
Investors
15
Lead investors
3
Founders
2
Articles
9

Founders and investors

Founders

Kate BlanchardRobin Smith

Lead investors

Haitong International Securities GroupHatteras Venture PartnersSyno Capital

Investors

Alexandria Venture InvestmentsDEFTA PartnersHatteras Venture PartnersLabCorpSekhmet Ventures